Drug safety evaluation of desogestrel

@article{Scala2013DrugSE,
  title={Drug safety evaluation of desogestrel},
  author={Carolina Scala and Umberto Leone Roberti Maggiore and Valentino Remorgida and Pier Luigi Venturini and Simone Ferrero},
  journal={Expert Opinion on Drug Safety},
  year={2013},
  volume={12},
  pages={433 - 444}
}
Introduction: Desogestrel (DSG) is a third-generation progestin. It is commonly used in various formulations for hormonal contraception including combinations with ethinyl estradiol (EE), progestin-only pill and subdermal implants. DSG is also used in menopausal patients for hormone replacement therapy (HRT). Areas covered: The current manuscript aims to review the available data on safety and tolerability of DSG in oral contraception and HRT. The material included in the manuscript was… 
Pharmacokinetic evaluation of desogestrel as a female contraceptive
TLDR
This is a review of the available data on the pharmacokinetics of DSG and ETN in hormonal contraception and its metabolite ETN is the compound of choice.
Advances in pharmacotherapy for treating endometriosis
TLDR
The treatments most recently proposed for endometriosis will be described in detail, including gonadotropin-releasing hormone (GnRH) antagonists, aromatase inhibitors (AIs) and the flexible extended combined oral contraceptive.
Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis
TLDR
This review aims to offer the reader a complete overview of pharmacokinetic (PK) and clinical efficacy of progestins for the treatment of endometriosis.
Current and Emerging Therapeutics for the Management of Endometriosis
TLDR
Because few data are available on long-term efficacy and safety of aromatase inhibitors they should be administered only in women with symptoms refractory to other conventional therapies in a clinical research setting.
A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy
TLDR
There is no solid evidence supporting that the use of combined oral contraceptives in women with PCOS increases the risk of cardiovascular or thromboembolic events compared with the general population.
Hormonal contraception in women with endometriosis: a systematic review
  • G. Grandi, F. Barra, F. Facchinetti
  • Medicine
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2019
TLDR
CHCs and POCs are effective for the relief of endometriosis-related dysmenorrhoea, pelvic pain and dyspareunia, and improve QoL, with insufficient evidence, however, to reach definitive conclusions about the overall superiority of any particular hormonal contraceptive.
Oral Desogestrel as Endometrial Preparation before Operative Hysteroscopy: A Systematic Review
TLDR
The data demonstrated that desogestrel may be considered as a hormonal pretreatment drug before hysteroscopic procedures, and was distinctly effective and assessed as helpful by the operating surgeon in numerous patients who were administered the pretreatment of 75 μg daily.
Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation
TLDR
Contraception for two groups of women: women with heart failure and women with cardiac transplantation, where pregnancy is high risk and should be avoided altogether for 1–2 years after transplantation.
In Vitro and In Vivo Evaluation of Desogestrel-Loaded Poly(D,L-lactic Acid) Nanoparticles
The aim of this study was to explore the synthesis parameters of desogestrel-polylactic acid nanoparticles (DG-PLA-NPs), optimise the preparation technology, and elucidate the in vitro release
Desogestrel‐only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open‐label comparative study
TLDR
To compare the efficacy of two hormonal therapies in treating symptoms caused by bowel endometriosis, a large number of women and their doctors believe that using a single hormonal treatment is more beneficial than using two different methods to treat symptoms.
...
1
2
...

References

SHOWING 1-10 OF 95 REFERENCES
Seventy‐Five Microgram Desogestrel Minipill, A New Perspective in Estrogen‐Free Contraception
TLDR
The high effectiveness of the DSG minipill is attributable to an almost constant inhibition of ovulation, as shown by the absence of elevated progesterone circulating levels and inhibition of follicular growth in the vast majority of cycles studied.
Pharmacokinetics of desogestrel.
The effect of a phasic oral contraceptive containing Desogestrel on seborrhea and acne
  • H. Kränzlin, M. Nap
  • Medicine
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2006
TLDR
Novial® effectively reduces seborrhea after only four cycles of treatment and may be a suitable oral contraceptive for women wishing to improve their facial skin condition.
Tolerability and clinical safety of Implanon®
TLDR
Implanon® is a well-tolerated and safe method of long-acting hormonal contraception for women and has little effect on metabolic and coagulation parameters.
The use of newer progestins for contraception.
The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea
TLDR
Cerazette® in this study set-up improved oestrogen-related symptoms and dysmenorrhoea in women affected and treatment was well accepted.
Hormonal contraceptives and venous thromboembolism: an epidemiological update.
A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.
TLDR
The results of this study indicate that a number of the characteristics of the women taking COCs affect the risk of VTE, and there is no evidence to support the hypothesis that there is any difference in risk between COC formulations containing under 50 microg ethinyloestradiol.
...
1
2
3
4
5
...